← Evidence map

ReviewDer Internist2019

[Orphan drugs from the perspective of the Drug Commission of the German Medical Association : Opportunities and challenges].

Wolf-Dieter LudwigPubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019

this papercites it

[Orphan drugs from the perspective of the Drug Commission of the German Medical Association : Opportunities and challenges]. | OpenQuestion